GlassScriptPhysician profile
Sergei Tikhonenkov
NPI 1104973908
$22,116.19
in general payments reported to CMS, 2019-2025
30 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $735 · 2021: $9,519 · 2022: $1,451 · 2023: $4,717 · 2024: $3,199 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,594 · Consulting Fee: $2,625 · Travel and Lodging: $1,253 · Education: $809 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,594.35 |
| Consulting Fee | $2,625.00 |
| Travel and Lodging | $1,252.80 |
| Education | $809.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,504.96 | 2019-2021 | |
| Nonagen Bioscience Corp | $2,625.00 | 2023 | Oncuria |
| Astellas Pharma US INC | $2,623.95 | 2019-2025 | Xtandi, Padcev, Veozah |
| Pfizer INC. | $1,660.08 | 2019-2025 | |
| Profound Medical Corp. | $1,252.80 | 2024 | Tulsa-Pro |
| Janssen Biotech, INC. | $1,183.74 | 2020-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $825.95 | 2023-2025 | Orgovyx |
| Boston Scientific Corporation | $646.13 | 2019-2025 | Spaceoar Vue System - 10ml, General - Kidney Stone Disease, Lithovue |
| Olympus America INC. | $609.92 | 2022-2025 | Itind System, Uropass, Soltive |
| Teleflex LLC | $496.26 | 2021-2025 | Urolift, Barrigel |
| Photocure INC | $326.56 | 2019-2022 | |
| Myovant Sciences INC. | $291.46 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $235.40 | 2020-2025 | |
| Neotract INC. | $146.72 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $107.82 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $98.58 | 2023 | Onli, Vapro, Vapro Plus Pocket |
| Immunitybio, INC. | $91.03 | 2025 | |
| Urogen Pharma, INC. | $75.06 | 2025 | |
| Allergan, INC. | $58.88 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $51.00 | 2022-2023 | Erleada, Balversa |
| Merck Sharp & Dohme LLC | $41.37 | 2020-2024 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $26.42 | 2023 | |
| Sun Pharmaceutical Industries INC. | $23.82 | 2022 | |
| Amgen INC. | $20.55 | 2019 | |
| Novo Nordisk INC | $20.51 | 2024 | Rivfloza |
| Ethicon US, LLC | $16.21 | 2024 | Stratafix, Surgicel Nu-Knit |
| Dendreon Pharmaceuticals LLC | $14.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.68 | 2021 | |
| Dentsply Ih Ab | $14.36 | 2024 | Lofric |
| Mallinckrodt Enterprises LLC | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergei Tikhonenkov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.